贵州三力制药股份有限公司 关于控股股东签署一致行动协议暨权益变动的提示性公告

Core Viewpoint - Guizhou Sanli Pharmaceutical Co., Ltd. has signed a concerted action agreement between its controlling shareholder Zhang Hai and Hainan Yuexin Pharmaceutical Investment Partnership, which collectively holds 48.68% of the company's shares, enhancing their influence over corporate decisions [2][11]. Group 1: Shareholder Information - After the signing of the concerted action agreement, the controlling shareholder and its concerted action parties hold a total of 199,056,487 shares, accounting for 48.68% of the total share capital [3][11]. - The agreement does not involve any changes in the individual shareholdings of the shareholders, but rather increases the combined shareholding percentage due to the signing of the agreement [2][11]. Group 2: Agreement Details - The parties involved in the agreement are Zhang Hai, the largest shareholder and actual controller of Guizhou Sanli, and Hainan Yuexin Pharmaceutical Investment Partnership, which holds 20,190,100 shares, representing 4.9373% of the total share capital [4]. - The agreement stipulates that both parties will communicate and reach consensus on proposals before submitting them to the board or shareholders' meeting [5][6]. Group 3: Duration and Commitments - The concerted action agreement is effective for 12 months from the date of signing, with the possibility of extension upon mutual agreement [7]. - Both parties commit to maintaining their rights and obligations under the agreement, regardless of any changes in their shareholding proportions during the agreement period [8][9].